Copyright
©The Author(s) 2018.
World J Gastroenterol. Jan 14, 2018; 24(2): 195-210
Published online Jan 14, 2018. doi: 10.3748/wjg.v24.i2.195
Published online Jan 14, 2018. doi: 10.3748/wjg.v24.i2.195
Figure 1 INT-767 treatment for 8 wk improves liver histopathology in ob/ob-NASH mice with biopsy-confirmed liver pathology.
A: Composite NAS and fibrosis stage before and after treatment intervention; B: Representative HE and PSR stainings. aP < 0.05, bP < 0.001 (χ2 test, vs vehicle controls).
- Citation: Roth JD, Feigh M, Veidal SS, Fensholdt LK, Rigbolt KT, Hansen HH, Chen LC, Petitjean M, Friley W, Vrang N, Jelsing J, Young M. INT-767 improves histopathological features in a diet-induced ob/ob mouse model of biopsy-confirmed non-alcoholic steatohepatitis. World J Gastroenterol 2018; 24(2): 195-210
- URL: https://www.wjgnet.com/1007-9327/full/v24/i2/195.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i2.195